Detalhe da pesquisa
1.
Capivasertib combines with docetaxel to enhance anti-tumour activity through inhibition of AKT-mediated survival mechanisms in prostate cancer.
Br J Cancer
; 130(8): 1377-1387, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38396173
2.
Multiomic profiling of breast cancer cells uncovers stress MAPK-associated sensitivity to AKT degradation.
Sci Signal
; 17(825): eadf2670, 2024 Feb 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38412255
3.
Prostate specific antigen enhances the innate defence of prostatic epithelium against Escherichia coli infection.
Prostate
; 73(14): 1529-37, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23818154
4.
Renal differentiation from adult spermatogonial stem cells.
Ren Fail
; 35(10): 1387-91, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23991628
5.
Combining the AKT inhibitor capivasertib and SERD fulvestrant is effective in palbociclib-resistant ER+ breast cancer preclinical models.
NPJ Breast Cancer
; 9(1): 64, 2023 Aug 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37543694
6.
Lineage Plasticity in SCLC Generates Non-Neuroendocrine Cells Primed for Vasculogenic Mimicry.
J Thorac Oncol
; 18(10): 1362-1385, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37455012
7.
The Next-Generation Oral Selective Estrogen Receptor Degrader Camizestrant (AZD9833) Suppresses ER+ Breast Cancer Growth and Overcomes Endocrine and CDK4/6 Inhibitor Resistance.
Cancer Res
; 83(23): 3989-4004, 2023 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37725704
8.
In situ lineage tracking of human prostatic epithelial stem cell fate reveals a common clonal origin for basal and luminal cells.
J Pathol
; 225(2): 181-8, 2011 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21898876
9.
VEGF pathway inhibition potentiates PARP inhibitor efficacy in ovarian cancer independent of BRCA status.
J Hematol Oncol
; 14(1): 186, 2021 11 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34742344
10.
The MEK5-ERK5 Kinase Axis Controls Lipid Metabolism in Small-Cell Lung Cancer.
Cancer Res
; 80(6): 1293-1303, 2020 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31969375
11.
Author Correction: Combining the AKT inhibitor capivasertib and SERD fulvestrant is effective in palbociclib-resistant ER+ breast cancer preclinical models.
NPJ Breast Cancer
; 9(1): 69, 2023 Aug 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-37596288
12.
Author Correction: Combining the AKT inhibitor capivasertib and SERD fulvestrant is effective in palbociclib-resistant ER+ breast cancer preclinical models.
NPJ Breast Cancer
; 9(1): 76, 2023 Sep 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37726304
13.
Multipotent Basal Stem Cells, Maintained in Localized Proximal Niches, Support Directed Long-Ranging Epithelial Flows in Human Prostates.
Cell Rep
; 20(7): 1609-1622, 2017 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28813673
14.
Functional networks inference from rule-based machine learning models.
BioData Min
; 9(1): 28, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27597880
15.
Vasculogenic mimicry in small cell lung cancer.
Nat Commun
; 7: 13322, 2016 11 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27827359
16.
SETD6 controls the expression of estrogen-responsive genes and proliferation of breast carcinoma cells.
Epigenetics
; 9(7): 942-50, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24751716
17.
A review of tasquinimod in the treatment of advanced prostate cancer.
Drug Des Devel Ther
; 7: 167-74, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23662046
18.
A novel model of urinary tract differentiation, tissue regeneration, and disease: reprogramming human prostate and bladder cells into induced pluripotent stem cells.
Eur Urol
; 64(5): 753-61, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23582880
19.
Human α(2)ß(1)(HI) CD133(+VE) epithelial prostate stem cells express low levels of active androgen receptor.
PLoS One
; 7(11): e48944, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-23145034
20.
Side population in human non-muscle invasive bladder cancer enriches for cancer stem cells that are maintained by MAPK signalling.
PLoS One
; 7(11): e50690, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-23226356